DK0957903T3 - Norbornen- og norbornandiolforbindelser til behandling af pigmenteringslidelser, neurodegenerative sygdomme eller proliferative hudlidelser - Google Patents

Norbornen- og norbornandiolforbindelser til behandling af pigmenteringslidelser, neurodegenerative sygdomme eller proliferative hudlidelser

Info

Publication number
DK0957903T3
DK0957903T3 DK97944319T DK97944319T DK0957903T3 DK 0957903 T3 DK0957903 T3 DK 0957903T3 DK 97944319 T DK97944319 T DK 97944319T DK 97944319 T DK97944319 T DK 97944319T DK 0957903 T3 DK0957903 T3 DK 0957903T3
Authority
DK
Denmark
Prior art keywords
disorders
norbornanediol
norbornene
compounds
treatment
Prior art date
Application number
DK97944319T
Other languages
Danish (da)
English (en)
Inventor
Krystyna Lesiak
David A Brown
Alexander A Khorlin
Wu Yun Ren
Original Assignee
Applied Genetics Inc Dermatics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Genetics Inc Dermatics filed Critical Applied Genetics Inc Dermatics
Application granted granted Critical
Publication of DK0957903T3 publication Critical patent/DK0957903T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
DK97944319T 1996-09-18 1997-09-18 Norbornen- og norbornandiolforbindelser til behandling af pigmenteringslidelser, neurodegenerative sygdomme eller proliferative hudlidelser DK0957903T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2657796P 1996-09-18 1996-09-18
US3594797P 1997-01-21 1997-01-21
US3686397P 1997-02-04 1997-02-04
US4859797P 1997-06-04 1997-06-04

Publications (1)

Publication Number Publication Date
DK0957903T3 true DK0957903T3 (da) 2005-11-21

Family

ID=27487517

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944319T DK0957903T3 (da) 1996-09-18 1997-09-18 Norbornen- og norbornandiolforbindelser til behandling af pigmenteringslidelser, neurodegenerative sygdomme eller proliferative hudlidelser

Country Status (9)

Country Link
US (2) US6294585B1 (de)
EP (1) EP0957903B1 (de)
AT (1) ATE301459T1 (de)
AU (1) AU740783B2 (de)
CA (1) CA2266496A1 (de)
DE (1) DE69733968T2 (de)
DK (1) DK0957903T3 (de)
ES (1) ES2245465T3 (de)
WO (1) WO1998011882A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214888B1 (en) 1996-09-18 2001-04-10 Applied Genetics Incorporated Dermatological compounds
US6623724B2 (en) * 1996-09-18 2003-09-23 Applied Genetics Incorporated Dermatics Dermatological compositions and methods
ES2245465T3 (es) 1996-09-18 2006-01-01 Applied Genetics Incorporated Dermatics Dioles de compuestos de norborneno y norbornano para el tratamiento de trastornos de la pigmentacion, enfermedades neurodegenerativas o enfermedades proliferativas de la piel.
JP2001511151A (ja) * 1997-02-04 2001-08-07 ザ ジェネラル ホスピタル コーポレイション 表皮又は皮膚疾患部の処理方法と形質転換動物
CA2238283C (en) 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US6267948B1 (en) * 1998-04-06 2001-07-31 Applied Genetics Incorporated Dermatics Dermatological formulations and methods
CA2334528A1 (en) * 1998-06-15 1999-12-23 Peter David Gluckman Regulation of tyrosine hydroxylase
IL132366A0 (en) * 1998-10-15 2001-03-19 Cell Pathways Inc Methods for identifying compounds for inhibition of neoplastic lesions and pharmaceutical compositions containing such compounds
US6359153B1 (en) * 1998-10-28 2002-03-19 Hyundai Electronics Industries Co., Ltd. Photoresist monomers and preparation thereof
EP1261572A4 (de) * 2000-03-10 2004-05-26 Applied Genetics Inc Dermatics Dermatologische verbindungen
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
DE10111050A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
US6682753B2 (en) * 2001-03-23 2004-01-27 Neuronz Limited Methods for promoting weight gain using GPE-related compounds
US20070004641A1 (en) * 2001-05-24 2007-01-04 Neuren Pharmaceuticals Limited Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamate
US7605177B2 (en) * 2001-05-24 2009-10-20 Neuren Pharmaceuticals Limited Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration
DE60232880D1 (de) 2001-05-24 2009-08-20 Neuren Pharmaceuticals Ltd Gpe-analoga und peptidomimetika
US7714020B2 (en) * 2001-05-24 2010-05-11 Neuren Pharmaceuticals Limited Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
EP1408757A4 (de) * 2001-07-02 2006-12-27 Wisconsin Alumni Res Found Verfahren und zusammensetzung zur verlängerung der verweilzeit von arzneistoffenim darm
US20040192638A1 (en) * 2001-07-02 2004-09-30 Oaks John A. Method and composition for prolonging the residence time of drugs in the gut
US6723755B2 (en) 2002-06-12 2004-04-20 Piotr Chomczynski Method of treating rosacea
FR2840530B1 (fr) * 2002-06-11 2004-12-24 Oreal Composition cosmetique comprenant un agent inducteur de l'expression de la dopachrome tautomerase (trp-2) pour lutter contre la canitie
AU2004242507B2 (en) * 2002-06-12 2009-02-19 Piotr Chomczynski Method of treating rosacea
US20040047919A1 (en) * 2002-06-13 2004-03-11 Board Of Regents, The University Of Texas System Methods and compositions involving aldose reductase inhibitors
FR2856926B1 (fr) * 2003-07-02 2005-09-30 Centre Nat Rech Scient Utilisation des n-alkanols comme activateurs du canal cftr
US9440089B2 (en) 2003-12-05 2016-09-13 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological injury or condition caused by a stroke
US9433797B2 (en) 2003-12-05 2016-09-06 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurodegenerative conditions
US8961385B2 (en) 2003-12-05 2015-02-24 Ivivi Health Sciences, Llc Devices and method for treatment of degenerative joint diseases with electromagnetic fields
US10350428B2 (en) 2014-11-04 2019-07-16 Endonovo Therapetics, Inc. Method and apparatus for electromagnetic treatment of living systems
US9656096B2 (en) 2003-12-05 2017-05-23 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic enhancement of biochemical signaling pathways for therapeutics and prophylaxis in plants, animals and humans
US9415233B2 (en) 2003-12-05 2016-08-16 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological pain
EP1740107B1 (de) 2004-04-19 2020-03-04 Ivivi Health Sciences, LLC Elektromagnetisches behandlungsgerät
JP2008500368A (ja) * 2004-05-27 2008-01-10 ミジェニックス コーポレイション 細胞保護のための２置換１７−イミノエストロゲン化合物
US7812057B2 (en) * 2004-08-25 2010-10-12 Molecular Research Center, Inc. Cosmetic compositions
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US9579298B2 (en) * 2004-12-02 2017-02-28 Piotr Chomczynski Antioxidant dietary supplement compositions and methods for maintaining healthy skin
FR2889808B1 (fr) 2005-08-17 2011-07-22 Oreal Utilisation de l'acide 8-hexadecene-1,16-dicarboxylique comme agent de soin destine a favoriser la cohesion de la couche cornee
WO2007048034A2 (en) * 2005-10-21 2007-04-26 Caritas St. Elizabeth Medical Center Of Boston, Inc. Use of androgens for the treatment of parkinson' s disease
KR101111020B1 (ko) * 2006-07-04 2012-03-13 주식회사 알엔에스 신규한 사이클릭 화합물의 유도체 및 그의 용도
EP2066393A1 (de) * 2006-09-20 2009-06-10 IVIVI Technologies, Inc. Elektromagnetische vorrichtung zur behandlung von atmungserkrankungen und verwendungsverfahren dafür
US20080229371A1 (en) * 2007-02-22 2008-09-18 Mick Colin K Digital multimedia network including method and apparatus for high speed user download of digital files
WO2008118844A1 (en) 2007-03-23 2008-10-02 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US8026217B2 (en) * 2007-10-03 2011-09-27 Florida Atlantic University Compositions and methods for treating neural anoxia and spreading depression
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
KR101050429B1 (ko) * 2009-03-18 2011-07-19 연세대학교 산학협력단 캠펜을 유효성분으로 포함하는 비만, 이상지방혈증, 지방간또는 인슐린 저항성 증후군의 예방 또는 치료용 조성물
CN101797243B (zh) * 2010-03-23 2012-01-18 广东药学院 一种含有左旋多巴和冰片的组合物及其应用
AU2011258553B2 (en) * 2010-05-27 2014-08-14 Targacept, Inc. Nicotinic receptor non-competitive antagonists
WO2012045079A2 (en) 2010-10-01 2012-04-05 Ivivi Health Sciences, Llc Method and apparatus for electromagnetic treatment of head cerebral and neural injury in animals and humans
ITMI20111260A1 (it) * 2011-07-06 2013-01-07 Carmelo Cutrupi Composizioni topiche per l'uso nella prevenzione e/o nel trattamento di dermatiti
US8343027B1 (en) 2012-01-30 2013-01-01 Ivivi Health Sciences, Llc Methods and devices for providing electromagnetic treatment in the presence of a metal-containing implant
US9457003B2 (en) * 2013-03-12 2016-10-04 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
US9320913B2 (en) 2014-04-16 2016-04-26 Rio Grande Neurosciences, Inc. Two-part pulsed electromagnetic field applicator for application of therapeutic energy
CN105693817B (zh) * 2014-11-27 2020-06-05 西北大学 一类三肽化合物及其制备方法与应用
WO2018089795A1 (en) 2016-11-10 2018-05-17 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT279052B (de) 1968-08-08 1970-02-25 Dragoco Gerberding Co Gmbh Lichtschutzmittel
DE2350315C2 (de) * 1973-10-06 1984-01-12 Johnson & Johnson GmbH, 4000 Düsseldorf Pharmazeutische und kosmetische Präparate zur äußerlichen Anwendung
US3956361A (en) 1974-05-23 1976-05-11 Ciba-Geigy Corporation Hindered phenolic derivatives of norbornane thioalcohols
US4102995A (en) * 1976-05-13 1978-07-25 Westwood Pharmaceuticals Inc. Tar gel formulation
DE3025187A1 (de) * 1980-07-03 1982-02-11 Henkel KGaA, 4000 Düsseldorf Neue riechstoffe, deren herstellung sowie diese enthaltende riechstoffkompositionen
US4647585A (en) 1984-11-08 1987-03-03 E. R. Squibb & Sons, Inc. Bicycloheptane substituted ethers
US5525635A (en) * 1986-02-04 1996-06-11 Moberg; Sven Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof
SE462139B (sv) * 1986-02-04 1990-05-14 Sven Moberg Farmaceutisk komposition, innehaallande propylenglykol och karbamid, foer behandling av bl.a. nagelsvamp och seborroiskt eksem
DE3724691C2 (de) * 1987-07-25 1999-03-18 Konrad Minninger Pharmazeutisches Mittel zur lokalen Therapie von schuppenden Hautkrankheiten
US5700450A (en) * 1988-03-30 1997-12-23 The Trustees Of Boston University Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof
US5352440A (en) * 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
DE3925634A1 (de) * 1989-08-03 1991-02-07 Bayer Ag Stabilisatordispersionen
US5190978A (en) * 1989-09-29 1993-03-02 Dai-Ichi Kogyo Seiyaku Co. Ltd. Carcinostatic compositions and methods
JP3013540B2 (ja) 1990-09-18 2000-02-28 住友化学工業株式会社 害虫忌避剤
US5190798A (en) * 1992-01-09 1993-03-02 Gilbert Bloch Paper-plastic film, fiberglass-reinforced sealing tape
US5587402A (en) 1992-04-09 1996-12-24 Wisconsin Alumni Research Foundation Regression of mammalian leukemia cell tumors
US5414019A (en) 1992-04-09 1995-05-09 Wisconsin Alumni Research Foundation Regression of mammalian carcinomas
US5602184A (en) 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
DE69331232T2 (de) * 1993-09-09 2002-07-25 Du Pont Wässrige Tintenzusammensetzung, die Mittel gegen das Einrollen von Papier enthält
US5434144A (en) * 1994-03-04 1995-07-18 The Procter & Gamble Company Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles
US5626839A (en) * 1994-11-08 1997-05-06 Scales-Medeiros; Virginia Light responsive self-tanning products and methods for use
BR9609820A (pt) * 1995-07-11 1999-07-06 Procter & Gamble Composições amaciantes de tecidos concentrados dispersíveis em água e estáveis
US5747532A (en) * 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
AU2099397A (en) * 1996-02-21 1997-09-10 Stoa S.A. Cosmetic, dermopharmaceutical or veterinary compositions for disinfecting human or animal skin
ES2245465T3 (es) 1996-09-18 2006-01-01 Applied Genetics Incorporated Dermatics Dioles de compuestos de norborneno y norbornano para el tratamiento de trastornos de la pigmentacion, enfermedades neurodegenerativas o enfermedades proliferativas de la piel.
WO1998055085A1 (en) * 1997-06-04 1998-12-10 Codon Pharmaceuticals, Inc. Pharmaceutical compositions and methods
CA2301016A1 (en) * 1997-08-21 1999-02-25 Johnson & Johnson Consumer Companies, Inc. Use of 17-.alpha.-estradiol for the treatment of aged or sundamaged ski n and/or skin atrophy

Also Published As

Publication number Publication date
DE69733968D1 (de) 2005-09-15
EP0957903B1 (de) 2005-08-10
AU740783B2 (en) 2001-11-15
EP0957903A1 (de) 1999-11-24
AU4584297A (en) 1998-04-14
US5990177A (en) 1999-11-23
EP0957903A4 (de) 2002-10-09
US6294585B1 (en) 2001-09-25
ATE301459T1 (de) 2005-08-15
WO1998011882A1 (en) 1998-03-26
ES2245465T3 (es) 2006-01-01
DE69733968T2 (de) 2006-06-01
CA2266496A1 (en) 1998-03-26

Similar Documents

Publication Publication Date Title
DK0957903T3 (da) Norbornen- og norbornandiolforbindelser til behandling af pigmenteringslidelser, neurodegenerative sygdomme eller proliferative hudlidelser
DK209088D0 (da) Medicinpraeparater, deres fremstilling og anvendelse
EA200200990A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы дельта человека
DE1019040T1 (de) Hemmung von p38 kinase aktivität durch arylharnstoff
ATE529109T1 (de) Hemmung der p38 kinase aktivität durch substituierte heterocyclische harnstoffe
DE1043995T1 (de) INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN
DK10389D0 (da) Fremgangsmaade til stimulering af haarvaekst
AR003989A1 (es) Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica.
PT1380587E (pt) Oxazolo, thiazolo e selenazolo -(4, 5-c )- naftiridina- 4- amina e analogos destes compostos
ATE397621T1 (de) Hemmer der interaktion zwischen p53 und mdm2
ATE296309T1 (de) Wasserlösliche adenosin kinase inhibitoren
DE69426334T2 (de) Parenterales Busulfan zur Behandlung von malignen Krankheiten
WO2004096159A3 (en) Saposin c-dops: a novel anti-tumor agent
DE69803200D1 (de) Verwendung von mindestens einen chrysanthemum gattungs extrakten zur förderung der haut- und/oder der haarepigmentierung
DK0553294T3 (da) Fremstillingen af sammensætninger til behandlingen af celleproliferationssygdomme
WO2002015870A3 (de) Substanzen zur induktion und intensivierung der bräuningsmechanismen der haut
ES2174103T3 (es) Uso de las secuencias reguladoras de wap o mmtv para expresion dirigida de genes heterologos ligados en celulas mamarias humanas, con inclusion de celulas de carcinoma mamario humano.
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
HUP0300923A2 (hu) RAF és RAS protein kinázt tartalmazó készítmények és alkalmazásuk angiogenezis módosítására
DK379886D0 (da) Praeparat og fremgangsmaade til behandling af svulster med udpg
ATE168698T1 (de) Zubereitungen zur verwendung bei der behandlung von psoriasis und von neuropsychiatrischen krankheiten
IT7824118A0 (it) Derivati di glicosidi benzopiraniche, loro procedimento di ottenimento e loro utilizzazione nella terapeutica umana.
NO20000007L (no) Anvendelse av veksthormon i sammensetninger til behandling av insulinresistens i hjertet samt for å øke protein-kinase-B(PKB)- aktivitet
DK1137420T3 (da) Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion
TR199901385T2 (xx) Piperidin t�revleri.